Brandon Capital, JCU is part of the Medical Research Commercialisation Fund (MRCF) which provides us with access to resources such as Brandon Capital. Dr Denise Hodge, CO-CEO of Journeytech arranged the meeting with Gos from Brandon Capital over Teams to discuss the commercialization of the new Anti-inflammatory compounds, that are filed for provisional patent. No funding was secured but they will be interested when we could establish mechanistic pathways for our novel drug lead molecules.
Phurpa Wangchuk
(Lecturer)
Organisation
Brandon Capital
Type of Engagement
SEMINAR_CONFERENCE
Other - Specify
N/A
Date
N/A
Description
JCU is part of the Medical Research Commercialisation Fund (MRCF) which provides us with access to resources such as Brandon Capital. Dr Denise Hodge, CO-CEO of Journeytech arranged the meeting with Gos from Brandon Capital over Teams to discuss the commercialization of the new Anti-inflammatory compounds, that are filed for provisional patent. No funding was secured but they will be interested when we could establish mechanistic pathways for our novel drug lead molecules.